Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soldano Ferrone

Showing results (241-250 of 334) with videos related to

Pageof 34
Sort By:
Frontiers in Oncology|April 29, 2021
High TIL, HLA, and Immune Checkpoint Expression in Conventional High-Grade and Dedifferentiated Chondrosarcoma and Poor Clinical Course of the DiseaseSjoerd P F T Nota, Ahmad Al-Sukaini, Shalin S Patel, et al.
Frontiers in Immunology|October 29, 2020
Peritumoral Immune Infiltrate as a Prognostic Biomarker in Thin MelanomaFrancesco Sabbatino, Giosuè Scognamiglio, Luigi Liguori, et al.
Neoplasia (New York, N.Y.)|July 2, 2009
Defective infiltration of natural killer cells in MICA/B-positive renal cell carcinoma involves beta(2)-integrin-mediated interactionGiuseppe Sconocchia, Giulio Cesare Spagnoli, Domenico Del Principe, et al.
Melanoma Research|March 14, 2008
A single chain immunotoxin, targeting the melanoma-associated chondroitin sulfate proteoglycan, is a potent inducer of apoptosis in cultured human melanoma cellsMichael Schwenkert, Katrin Birkholz, Michael Schwemmlein, et al.
Physical Biology|January 10, 2015
Limited genomic heterogeneity of circulating melanoma cells in advanced stage patientsCarmen Ruiz, Julia Li, Madelyn S Luttgen, et al.
International Journal of Cancer|August 10, 2019
CD16-158-valine chimeric receptor T cells overcome the resistance of KRAS-mutated colorectal carcinoma cells to cetuximabRoberto Arriga, Sara Caratelli, Giulia Lanzilli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2012
Role of Apollon in human melanoma resistance to antitumor agents that activate the intrinsic or the extrinsic apoptosis pathwaysElena Tassi, Marina Zanon, Claudia Vegetti, et al.
Breast Cancer Research : BCR|June 11, 2011
Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cellsCraig A Cooney, Fariba Jousheghany, Aiwei Yao-Borengasser, et al.
The Oncologist|May 9, 2023
Association of Tumor Cell Metabolic Subtype and Immune Response With the Clinical Course of Hepatocellular CarcinomaXiaolin Wei, Theodoros Michelakos, Qian He, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2011
Targeting ALDH(bright) human carcinoma-initiating cells with ALDH1A1-specific CD8⁺ T cellsCarmen Visus, Yangyang Wang, Antonio Lozano-Leon, et al.
Pageof 34

Showing results (241-250 of 334) with videos related to

Sort By:
Pageof 34
Frontiers in Oncology|April 29, 2021
High TIL, HLA, and Immune Checkpoint Expression in Conventional High-Grade and Dedifferentiated Chondrosarcoma and Poor Clinical Course of the DiseaseSjoerd P F T Nota, Ahmad Al-Sukaini, Shalin S Patel, et al.
Frontiers in Immunology|October 29, 2020
Peritumoral Immune Infiltrate as a Prognostic Biomarker in Thin MelanomaFrancesco Sabbatino, Giosuè Scognamiglio, Luigi Liguori, et al.
Neoplasia (New York, N.Y.)|July 2, 2009
Defective infiltration of natural killer cells in MICA/B-positive renal cell carcinoma involves beta(2)-integrin-mediated interactionGiuseppe Sconocchia, Giulio Cesare Spagnoli, Domenico Del Principe, et al.
Melanoma Research|March 14, 2008
A single chain immunotoxin, targeting the melanoma-associated chondroitin sulfate proteoglycan, is a potent inducer of apoptosis in cultured human melanoma cellsMichael Schwenkert, Katrin Birkholz, Michael Schwemmlein, et al.
Physical Biology|January 10, 2015
Limited genomic heterogeneity of circulating melanoma cells in advanced stage patientsCarmen Ruiz, Julia Li, Madelyn S Luttgen, et al.
International Journal of Cancer|August 10, 2019
CD16-158-valine chimeric receptor T cells overcome the resistance of KRAS-mutated colorectal carcinoma cells to cetuximabRoberto Arriga, Sara Caratelli, Giulia Lanzilli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2012
Role of Apollon in human melanoma resistance to antitumor agents that activate the intrinsic or the extrinsic apoptosis pathwaysElena Tassi, Marina Zanon, Claudia Vegetti, et al.
Breast Cancer Research : BCR|June 11, 2011
Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cellsCraig A Cooney, Fariba Jousheghany, Aiwei Yao-Borengasser, et al.
The Oncologist|May 9, 2023
Association of Tumor Cell Metabolic Subtype and Immune Response With the Clinical Course of Hepatocellular CarcinomaXiaolin Wei, Theodoros Michelakos, Qian He, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2011
Targeting ALDH(bright) human carcinoma-initiating cells with ALDH1A1-specific CD8⁺ T cellsCarmen Visus, Yangyang Wang, Antonio Lozano-Leon, et al.
Pageof 34